Skip to main content
. 2018 Dec 11;9(6):e00955-18. doi: 10.1128/mBio.00955-18

FIGĀ 6.

FIGĀ 6

Sera from HIV-1-infected patients contain high titers of neutralizing antibodies against V2 loop tyrosine mutants. Neutralization sensitivity of HIV-1 JR-CSF (tier 2) V2 loop tyrosine mutants to potently neutralizing (top 4 panels) or weakly neutralizing (bottom two panels) patient sera. The neutralization tests were performed using the TZM-bl assay.